Clinical Trials in Boston

Showing 10901-10920 of 15,299 trials

Modified Ablation Guided by Ibutilide Use in Chronic Atrial Fibrillation

NCT01014741

Procedures for ablation of persistent or long lasting atrial fibrillation are frequently long and require extensive ablation. Some electrophysiologists administer the drug ibutilide during these procedures to help organize the fibrillatory activity of the left atrium with the hope that this may shorten the length of the procedure and duration of ablation needed. Currently there is no standardized approach of administering the drug ibutilide during these procedures, thus the investigators cannot be certain that administering this drug does in fact facilitate the procedure. The aim of the MAGIC-AF Trial is to see if administering a standard dose of the drug ibutilide at a standard time in the procedure can allow for a reduction in the ablation procedure time. The investigators hypothesize that administering ibutilide during these procedures will result in a reduction in the procedure and ablation time required.

Persistent Atrial Fibrillation

Vivek Reddy200 participantsStarted Oct 2009

Sacramento, California, United States • Boston, Massachusetts, United States • Boston, Massachusetts, United States +4 more locations

COMPLETEDPhase 2< 1 mile

Safety and Efficacy Study of a New Antiviral Drug to Prevent Cytomegalovirus Reactivation in Bone Marrow Transplanted Patients

NCT01063829

The aim of the study is to find out whether AIC246 is safe and efficacious in lowering the chances of the cytomegalovirus becoming active again and causing illness after an HBPC transplant (allogeneic stem cell transplant).

HCMV Reactivation or HCMV End-Organ Disease

AiCuris Anti-infective Cures AG133 participantsStarted Mar 2010

Los Angeles, California, United States • Stanford, California, United States • Denver, Colorado, United States +21 more locations

Modified Ablation Guided by Ibutilide Use in Chronic Atrial Fibrillation

Safety and Efficacy Study of a New Antiviral Drug to Prevent Cytomegalovirus Reactivation in Bone Marrow Transplanted Patients

Find Trials by Condition in Boston

Our Whole Lives: Online Chronic Pain Management

A Pilot Study of Acupuncture Treatment for Dysphagia

VALTREX Once Daily For Viral Shedding In Herpes Simplex Virus 2 (HSV-2) Seropositive Subjects. VALTREX® Tablet is a Trademark of GlaxoSmithKline Group of Companies.

Safety and Pharmacokinetics of Abicipar Pegol Intravitreal Injections in Patients With Neovascular AMD

A Phase II Trial of Regadenoson in Sickle Cell Anemia

Expanded Access Program of Ponatinib

Retrospective Review of Mechanically Ventilated Patients Using a Continuous Data Collection System.

Proactive Psychiatry Consultation for Patients With Cancer and Severe Mental Illness

Comparing Google With A Focused Diabetes Search Engine

Impact of Cerebellar Mass Resection on Pain Processing

Study of Bendamustine Hydrochloride and Rituximab (BR) Compared With R-CVP or R-CHOP in the First-Line Treatment of Patients With Advanced Indolent Non-Hodgkin's Lymphoma (NHL) or Mantle Cell Lymphoma (MCL) - Referred to as the BRIGHT Study

Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis

Study of Ruxolitinib in Colorectal Cancer Patients

Safety and Efficacy of INCB013739 Plus Metformin Compared to Metformin Alone on Glycemic Control in Type 2 Diabetics

Study HZA106827: Efficacy/Safety Study of Fluticasone Furoate/Vilanterol (GW642444) in Adult and Adolescent Asthmatics

A Pharmacokinetic Study of Erlotinib in Cancer Patients With Advanced Solid Tumors, With Adequate and Moderately Impaired Hepatic Function

Environmental Triggers Of Cardiometabolic Disease

A Study of The Impact of Severe Hepatic Impairment on the Pharmacokinetics and Safety of Vemurafenib in BRAF V600 Mutation-Positive Cancer Participants